Results 31 to 40 of about 410,880 (314)

Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer [PDF]

, 2007
Background: Patients with metastatic breast cancer (MBC) are increasingly exposed to anthracyclines and taxanes either during treatment of primary breast cancer or during initial therapy of metastatic disease.
Vehling-Kaiser, U., Melchert, F., Koelbl, H., Maubach, P., Stemmler, H. J., Scharl, A., Heinemann, Volker, Weber, B., Meerpohl, H., Kalischefski, B., Laessig, D., Stauch, M., Morack, G., Fasching, P. A.   +13 more
core   +1 more source

Living into old age with the consequences of breast cancer [PDF]

, 2013
Purpose of the research: breast cancer survival rates are improving with over 60% likely to live 20 years. As 30% diagnoses occur in women over 70 the prevalence of breast cancer survivors living into older age is increasing.
Foster, Claire L., Fenlon, Deborah, Coleman, Peter, Brooks, Cindy, Stephens, Richard, Addington-Hall, Julia, Foster, Claire, Walsh, Bronagh, Seymour, Jane, Payne, Sheila, Addington-hall, Julia M., Deborah Fenlon, Simmonds, Peter, Frankland, Jane   +13 more
core   +1 more source

Microbiome and Breast Cancer: New Role for an Ancient Population

Frontiers in Oncology, 2020
There are many risk factors associated with breast cancer (BC) such as the familial history of BC, using hormone replacement therapy, obesity, personal habits, and other clinical factors; however, not all BC cases are attributed to these risk factors ...
Zahra Eslami-S, Zahra Eslami-S, Keivan Majidzadeh-A, Sina Halvaei, Fatemeh Babapirali, Fatemeh Babapirali, Rezvan Esmaeili   +6 more
doaj   +1 more source

Staging Investigations in Breast Cancer: Collective Opinion of UK Breast Surgeons [PDF]

, 2013
Introduction. Certain clinicopathological factors are associated with a higher likelihood of distant metastases in primary breast cancer. However, there remains inconsistency in which patients undergo formal staging for distant metastasis and the most ...
R. I. Cutress, N. Chand, Agrawal, A., Cutress, R.I., A. Agrawal, Oeppen, R.S., Chand, N., R. S. Oeppen   +7 more
core   +1 more source

Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran [PDF]

, 2009
Background: while there has been much research regarding risk factors and prognostic factors for breast cancer in general, research specific to Iran is sparse.
Talei, Abdolrasoul, Rezaianzadeh, Abbas, Daniel Reidpath, Reidpath Daniel, Reidpath, D, Peacock, J, Hosseini, SV, Talei Abdolrasoul, Hosseini, Seyed Vahid, Hosseini, Seyed Vahid, Seyed Hosseini, Rezaianzadeh Abbas, Davood Mehrabani, Talei, A, Janet Peacock, Hoseini Seyed, Mehrabani, D, Mehrabani Davood, Rezaianzadeh, A, Peacock, Janet, Hosseini, S.V, Peacock Janet, Seyed Vahid Hosseini, Peacock, J.L, Mehrabani, Davood, Reidpath, Daniel, Abdolrasoul Talei, Reidpath, DD, Abbas Rezaianzadeh   +28 more
core   +1 more source

Phosphatidylinositol 4‐kinase as a target of pathogens—friend or foe?

FEBS Letters, EarlyView.
This graphical summary illustrates the roles of phosphatidylinositol 4‐kinases (PI4Ks). PI4Ks regulate key cellular processes and can be hijacked by pathogens, such as viruses, bacteria and parasites, to support their intracellular replication. Their dual role as essential host enzymes and pathogen cofactors makes them promising drug targets.
Ana C. Mendes, Guilherme M. Azevedo, Amanda P. Barcellos, Diana Bahia   +3 more
wiley   +1 more source

A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial [PDF]

, 2013
Background: Neo-tAnGo, a National Cancer Research Network (NCRN) multicentre randomised neoadjuvant chemotherapy trial in early breast cancer, enroled 831 patients in the United Kingdom.
K Walland, N Fenwick, M Iddawela, E Provenzano, Walland, K., Abraham, J. (Janet), Grier, Anna, L Hiller, J Abraham, A Grier, Fenwick, Nicola, Bowden, S. (Sarah), Iddawela, M., Caldas, C., H M Earl, R Champ, S Bowden, J Dunn, Vallier, A. -L., Champ, R., Earl, Helena M., C Caldas, Dunn, Janet A., Hiller, Louise, A-L Vallier, Provenzano, E.   +25 more
core   +1 more source

Irregular screening participation increases advanced stage breast cancer at diagnosis: A population-based study

Breast, 2022
Objective: To evaluate the effect of irregular screening behaviour on the risk of advanced stage breast cancer at diagnosis in Flanders. Methods: All women aged 50–69 who were invited to the organized breast cancer screening and diagnosed with breast ...
L. Ding, M.J.W. Greuter, I. Truyen, M. Goossens, H. De Schutter, G.H. de Bock, G. Van Hal   +6 more
doaj   +1 more source

Three phosphatase families form a community: The phosphohydrolases that act upon inositol pyrophosphates

FEBS Letters, EarlyView.
Inositol pyrophosphates are energy‐rich signaling molecules that perform critical functions in cells. Three different families of phosphatases hydrolyze the β phosphate of the inositol pyrophosphate molecules: two have narrow specificities and one is promiscuous.
Ronda J. Rolfes
wiley   +1 more source

Bevacizumab for Advanced Breast Cancer [PDF]

Hematology/Oncology Clinics of North America, 2007
Tumor angiogenesis is an important step in breast cancer development, progression, invasion and metastasis. Proangiogenic factors such as VEGF regulate angiogenesis and are targets for drug development. Bevacizumab, an anti-VEGF antibody, has demonstrated significant clinical benefit in several solid tumors, including breast cancer.
Shari B, Goldfarb, Tiffany A, Traina, Maura N, Dickler   +2 more
openaire   +3 more sources